Kim Brouwer
Document Actions
Recent Presentations
“Hepatobiliary Transport: Mechanisms, Model Systems and Implications in Drug Development”
Merck Research Laboratories, Westpoint, Pennsylvania, January, 2002.
“Hepatobiliary Transport: Mechanisms, Model Systems and Implications for Drug Development”
Janssen Pharmaceutica N.V., Beerse, Belgium, March, 2002.
“Hepatobiliary Transport: Mechanisms, Model Systems and Implications for Drug Development”
3-Dimensional Pharmaceuticals, Exton, Pennsylvania, May, 2002.
“Graduate Student Involvement in Clinical Research”
NIGMS Pharmacological Sciences Training Grants Meeting: What IS Training in the Pharmacological Sciences? Washington, D.C., August, 2002.
“Role of Hepatic Transporters”
Fifth Annual Land O’Lakes Conference on Drug Metabolism/Applied Pharmacokinetics, Merrimac, Wisconsin, September, 2002.
“Principles of Biopharmaceutics and Pharmacokinetics”
FDA Symposium on Controlled Release of Solid Oral Dosage Forms, Rockville, Maryland, September, 2002.
“Membrane Vesicles and Sandwich-Cultured Hepatocytes as In Vitro Models to Evaluate Drug Transport”
American Association of Pharmaceutical Scientists Workshop on Drug Transport: From the Bench to the Bedside, Invited Symposium Presentation, Atlanta, Georgia, February, 2003
"What Will Be Your Role In The Pharmacy Profession In 2030? How Will You Get The Training You Need For That Job You Are Dreaming Of?"
Oregon State University College of Pharmacy; Corvallis, Oregon. April, 2003.
"Preparing the Next Generation of Pharmaceutical Scientists: Case Studies of Mechanisms and Model Systems in Hepatobiliary Transport"
Keynote Address, Oregon State University College of Pharmacy Research Retreat; Corvallis, Oregon. April, 2003.
“In Vitro Models for Estimating Hepatobiliary Clearance”
American Association of Pharmaceutical Scientists Workshop on Pharmaceutical Profiling in Drug Discovery for Lead Selection, Invited Symposium Presentation, Whippany, New Jersey, May, 2003.
“Hepatic Transport and Hepatotoxicity: Mechanisms, Model Systems and Implications in Drug Development”
GlaxoSmithKline, Research Triangle Park, North Carolina, May, 2003.
“Use of Sandwich-Cultured Hepatocytes to Predict Biliary Excretion of Drugs, Evaluate Alterations in Hepatic Drug Transport, and Define Mechanisms of Interaction”
Gordon Research Conference (Drug Metabolism); Plymouth, New Hampshire. July, 2003.
“Membrane Vesicles and Sandwich-Cultured Hepatocytes as In Vitro Models to Evaluate Drug Transport”
14th North American ISSX Meeting, Invited Short Course Speaker, Providence, Rhode Island, October, 2003.
“Use of Sandwich-Cultured Hepatocytes to Evaluate Mechanisms of Hepatic Transport and Hepatotoxicity”
Washington State University College of Pharmacy, Pullman, Washington, November, 2003.
“Role of Transporters in Hepatic Uptake and Clearance”
Drug Metabolism Discussion Group, Research Triangle Park, February, 2004.
“Hepatic Transport Proteins: Model Systems of Hepatobiliary Transport and Relevance in Drug Development”
Keynote Speaker, Transporter Jamboree, Pfizer, Inc., Ann Arbor, Michigan. April, 2004.
"Coordinated Pharm.D. and Ph.D. Programs: Building Bridges from the Bench to the Clinic"
ASPET Teaching Institute, FASEB Annual Meeting, Washington, D.C., April, 2004.
“Isolated Perfused Liver and Hepatocyte Sandwich Culture to Predict Biliary Excretion”
European Federation for Pharmaceutical Sciences Conference on Drug Transporters: Integrative Approaches in ADME Research, Copenhagen, Denmark, April, 2004.
“Application of Pharmacogenetics in Clinical Practice and Therapeutic Drug Monitoring”
Pharmaceutical Sciences World Congress (PSWC2004), Kyoto, Japan, May 2004.
“Role of Transport Proteins in Hepatobiliary Excretion”
8th World Congress on Clinical Pharmacology and Therapeutics (CPT2004), Brisbane, Australia, August, 2004.
“Methods to Study the Functional Effects of Efflux Pumps in Biomembranes”
“Hepatic Transporters”
“Hepatic Cell Model Systems for Studying Hepatobiliary Transport”
“Computational, Cell Culture and Physicochemical Methods in Preclinical Pharmacokinetics” Post-Graduate Course organized by the Finnish Graduate School for Pharmaceutical Research and Graduate School ESPOM, Helsinki, Finland, December, 2004.
“Transporters (Phase III): Outline of Transporters and Role in Human Xenobiotic Processing”
“Human Metabolism of Public Health-Related, Deployment-Related, Industrial and Agricultural Chemicals” Short Course organized by North Carolina State Univeristy, Raleigh, North Carolina, January, 2005.
“In Vitro Models for Estimating Hepatobiliary Clearance”
ADMET-2 Conference, San Diego, California, February, 2005.
“Hepatotoxicity and Drug Transporters”
AAPS Workshop on Drug Transporters in ADME: From the Bench to the Bedside, Parsippany, NJ, March, 2005.
“The Role of Biliary Clearance in Drug Elimination”
37th Annual Pharmaceutics Graduate Student Research Meeting, Lawrence, KS, June 2005.